Fibrinogenopenia

Fibrinogenopenia (from the Greek fibrinogeno - “fibrin” and the Greek pénos - “protein, foam”) is a pathological condition in which the level of fibrinogen in the blood decreases. Fibrinogen is one of the main blood clotting factors that plays an important role in the formation of blood clots and wound healing.

Fibrinogenopenia can be caused by a variety of reasons, including genetic disorders in fibrinogen synthesis, infections, autoimmune diseases, medications, and some types of cancer.

Symptoms of a fibrinogenopenic state may include increased bleeding, delayed bleeding control, and an increased risk of thrombosis.

To diagnose fibrinogenopia, a blood test is used to determine fibrinogen levels. Treatment depends on the cause of fibrinogenopia and may include medications that affect blood clotting and lifestyle changes, such as limiting physical activity or using compression stockings.

It is important to note that fibrinogenopia can be life-threatening, so if symptoms appear, you should consult a doctor for prompt diagnosis and treatment.

Fibrinogen is one of the main blood clotting factors, related to glycoproteins, one of the main components of blood plasma in humans and other animals. As a rule, its main function is to create a blood clot. Patients with thrombophilia may experience a decrease in fibrinogen levels, which underlies their pathogenesis. Laboratory determination of this parameter in some cases helps with